XML 105 R91.htm IDEA: XBRL DOCUMENT v3.22.0.1
Payroll costs, share based payments and management incentive schemes - Non Executive Director Restricted Share Awards (Details)
1 Months Ended 12 Months Ended
Jun. 30, 2021
EUR (€)
shares
Jun. 30, 2021
$ / shares
Jun. 17, 2020
shares
$ / shares
Jun. 14, 2019
EUR (€)
shares
Jun. 14, 2019
$ / shares
Jun. 19, 2018
shares
$ / shares
May 31, 2020
shares
Jul. 31, 2019
shares
Dec. 31, 2021
EUR (€)
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
EUR (€)
Dec. 31, 2019
EUR (€)
shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                        
Share based payment charge | €                 € 5,100,000   € 9,000,000.0 € 14,900,000
Share based compensation reserve                        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                        
Share based payment charge | €                 € 5,100,000   9,000,000.0 14,900,000
Restricted Shares                        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                        
New awards granted in the period                 820,202 820,202    
Number of equity instruments exercised (in shares)                 1,861,826 1,861,826    
Non-Executive Director                        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                        
Expense from share-based payment transactions with employees | €                 € 800,000   € 700,000 € 900,000
Non-Executive Director | Restricted Shares                        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                        
Number of shares issued per director | $                   $ 100,000    
New awards granted in the period 24,759   32,140 39,370   32,172            
Share price (in Dollars per share) | $ / shares   $ 30.14 $ 21.78   $ 20.74              
Number of equity instruments exercised (in shares) 32,140   34,447 44,272     49,196 2,460       56,250
Reclassification of awards for settlement of tax liabilities 7,734   8,656 12,100                
Exercise price (in dollars per share) | $ / shares   $ 28.27 $ 21.78   $ 20.32 $ 18.07            
Non-Executive Director | Restricted Shares | Share based compensation reserve                        
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items]                        
Share based payment charge | € € 0.2     € 100,000